My Size Q2 Loss Widens 289% as Cash Drops to $453K; Going Concern and Nasdaq MVLS Deficiency Flagged
MYSZ sits 17% above its 52-week low of $2.643 on elevated volume (6.6× avg).
Summary
My Size's Q2 loss widened to $1.75M while cash dropped to $453K, triggering a going concern warning and revealing a Nasdaq MVLS deficiency of $2.3M against a $5.0M threshold.
Key Events · Earnings and Guidance · MYSZ
-
Q2 Loss Widens 289%
Net loss for Q2 2026 was $1.75M, up from $450K in Q2 2025, driven by higher operating expenses across all segments.
-
Cash Drops to $453K
Cash and cash equivalents fell to $453K as of June 30, 2026, from $2.3M at December 31, 2025, with management stating existing cash funds operations for less than 12 months.
-
Going Concern Warning Reiterated
Management expresses substantial doubt about the company's ability to continue as a going concern, citing constrained liquidity and imminent risk of default on debt obligations.
-
Nasdaq MVLS Deficiency
As of August 13, 2026, MVLS was approximately $2.3M, below the $5.0M threshold under Nasdaq's new rule (currently stayed pending SEC review), adding a second delisting risk.
Analysis · MYSZ · Technology
My Size's Q2 2026 results show a sharply deteriorating financial position. Revenue grew 53% to $3.07M, but net loss ballooned 289% to $1.75M, and cash and equivalents fell to just $453K from $2.3M at year-end. Management reiterates substantial doubt about its ability to continue as a going concern, stating existing cash funds operations for less than 12 months. The company also discloses its Market Value of Listed Securities is approximately $2.3M, below the $5.0M threshold under Nasdaq's new MVLS rule (currently stayed pending SEC review), creating a second delisting risk alongside the minimum bid price issue. The 1-for-8 reverse split executed August 12 was designed to address the bid price deficiency, but the MVLS shortfall remains unresolved. A litigation settlement of NIS 425K (~$143K) adds to near-term cash obligations. This filing quantifies the severity of the liquidity crisis and the dual Nasdaq compliance threats.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MYSZ was trading at $3.08 on NASDAQ in the Technology sector, with a market capitalization of approximately $18M. The 52-week trading range was $2.64 to $11.84. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.